Vapotherm Inc (NYSE:VAPO) Director Elizabeth H. Weatherman Acquires 8,382 Shares

Vapotherm Inc (NYSE:VAPO) Director Elizabeth H. Weatherman acquired 8,382 shares of Vapotherm stock in a transaction on Friday, September 6th. The stock was purchased at an average price of $11.38 per share, with a total value of $95,387.16.

Vapotherm stock traded down $1.71 on Monday, hitting $9.56. The company’s stock had a trading volume of 4,905 shares, compared to its average volume of 208,052. The firm has a market cap of $194.59 million and a P/E ratio of -0.68. The company has a quick ratio of 4.34, a current ratio of 5.22 and a debt-to-equity ratio of 1.42. The company has a fifty day moving average price of $14.63 and a 200-day moving average price of $17.92. Vapotherm Inc has a one year low of $9.31 and a one year high of $24.63.

Vapotherm (NYSE:VAPO) last announced its quarterly earnings data on Monday, July 29th. The company reported ($0.76) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.81) by $0.05. The business had revenue of $11.99 million during the quarter, compared to analyst estimates of $11.90 million. Analysts anticipate that Vapotherm Inc will post -3.07 EPS for the current year.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Perceptive Advisors LLC raised its position in Vapotherm by 12.7% in the 2nd quarter. Perceptive Advisors LLC now owns 1,404,470 shares of the company’s stock valued at $32,302,000 after buying an additional 158,155 shares during the last quarter. First Light Asset Management LLC grew its stake in shares of Vapotherm by 24.6% in the 2nd quarter. First Light Asset Management LLC now owns 496,969 shares of the company’s stock worth $11,430,000 after acquiring an additional 97,977 shares in the last quarter. Marshall Wace North America L.P. grew its stake in shares of Vapotherm by 165.6% in the 2nd quarter. Marshall Wace North America L.P. now owns 21,667 shares of the company’s stock worth $498,000 after acquiring an additional 13,510 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Vapotherm by 60.2% in the 2nd quarter. Vanguard Group Inc. now owns 376,660 shares of the company’s stock worth $8,663,000 after acquiring an additional 141,539 shares in the last quarter. Finally, BlackRock Inc. raised its holdings in shares of Vapotherm by 24.7% in the second quarter. BlackRock Inc. now owns 292,171 shares of the company’s stock valued at $6,719,000 after purchasing an additional 57,950 shares during the last quarter. 50.85% of the stock is currently owned by institutional investors and hedge funds.

Separately, Zacks Investment Research upgraded Vapotherm from a “hold” rating to a “buy” rating and set a $18.00 price objective on the stock in a research report on Friday, August 2nd. Five investment analysts have rated the stock with a buy rating, Vapotherm has an average rating of “Buy” and an average price target of $23.67.

Vapotherm Company Profile

Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.

Featured Story: Are FAANG stocks a good investment?

Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.